nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO4C1—Methotrexate—systemic scleroderma	0.11	0.133	CbGbCtD
Levothyroxine—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.107	0.13	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—systemic scleroderma	0.077	0.0931	CbGbCtD
Levothyroxine—CYP2C8—Mometasone—systemic scleroderma	0.0664	0.0802	CbGbCtD
Levothyroxine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0625	0.0755	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—systemic scleroderma	0.0529	0.064	CbGbCtD
Levothyroxine—ALB—Captopril—systemic scleroderma	0.0434	0.0525	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—systemic scleroderma	0.043	0.052	CbGbCtD
Levothyroxine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0342	0.0413	CbGbCtD
Levothyroxine—ABCB1—Lisinopril—systemic scleroderma	0.0304	0.0367	CbGbCtD
Levothyroxine—ALB—Prednisone—systemic scleroderma	0.0273	0.033	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—systemic scleroderma	0.0265	0.0321	CbGbCtD
Levothyroxine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0264	0.0319	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—systemic scleroderma	0.025	0.0303	CbGbCtD
Levothyroxine—ABCB1—Captopril—systemic scleroderma	0.0227	0.0275	CbGbCtD
Levothyroxine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0179	0.0216	CbGbCtD
Levothyroxine—ABCB1—Prednisone—systemic scleroderma	0.0143	0.0173	CbGbCtD
Levothyroxine—ALB—Methotrexate—systemic scleroderma	0.0137	0.0166	CbGbCtD
Levothyroxine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0107	0.013	CbGbCtD
Levothyroxine—CYP3A4—Prednisone—systemic scleroderma	0.00857	0.0104	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—systemic scleroderma	0.00718	0.00867	CbGbCtD
Levothyroxine—SLC7A5—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.00461	0.829	CbGdCrCtD
Levothyroxine—THRA—connective tissue—systemic scleroderma	0.00135	0.0746	CbGeAlD
Levothyroxine—SLC7A5—connective tissue—systemic scleroderma	0.00103	0.0569	CbGeAlD
Levothyroxine—TTR—connective tissue—systemic scleroderma	0.001	0.0554	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—systemic scleroderma	0.000943	0.0521	CbGeAlD
Levothyroxine—SLC7A5—skin of body—systemic scleroderma	0.000931	0.0514	CbGeAlD
Levothyroxine—THRB—tendon—systemic scleroderma	0.000929	0.0513	CbGeAlD
Levothyroxine—THRA—tendon—systemic scleroderma	0.000929	0.0513	CbGeAlD
Levothyroxine—SLCO4C1—lung—systemic scleroderma	0.00085	0.0469	CbGeAlD
Levothyroxine—SLCO1B3—lung—systemic scleroderma	0.000826	0.0456	CbGeAlD
Levothyroxine—THRA—lung—systemic scleroderma	0.000815	0.045	CbGeAlD
Levothyroxine—THRB—lung—systemic scleroderma	0.000815	0.045	CbGeAlD
Levothyroxine—SLC7A5—digestive system—systemic scleroderma	0.000745	0.0411	CbGeAlD
Levothyroxine—SLC16A2—lung—systemic scleroderma	0.000738	0.0408	CbGeAlD
Levothyroxine—TTR—digestive system—systemic scleroderma	0.000725	0.04	CbGeAlD
Levothyroxine—SLC7A5—tendon—systemic scleroderma	0.000709	0.0391	CbGeAlD
Levothyroxine—SLCO4A1—digestive system—systemic scleroderma	0.00065	0.0359	CbGeAlD
Levothyroxine—SLC7A5—lung—systemic scleroderma	0.000622	0.0343	CbGeAlD
Levothyroxine—SLC7A5—Desoximetasone—Mometasone—systemic scleroderma	0.000617	0.111	CbGdCrCtD
Levothyroxine—TTR—lung—systemic scleroderma	0.000606	0.0334	CbGeAlD
Levothyroxine—SLCO1B1—digestive system—systemic scleroderma	0.000572	0.0316	CbGeAlD
Levothyroxine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000565	0.00381	CcSEcCtD
Levothyroxine—Alopecia—Azathioprine—systemic scleroderma	0.000564	0.00381	CcSEcCtD
Levothyroxine—Palpitations—Captopril—systemic scleroderma	0.000563	0.0038	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000561	0.00378	CcSEcCtD
Levothyroxine—Sweating—Lisinopril—systemic scleroderma	0.000553	0.00373	CcSEcCtD
Levothyroxine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00373	CcSEcCtD
Levothyroxine—Urticaria—Pentoxifylline—systemic scleroderma	0.000545	0.00368	CcSEcCtD
Levothyroxine—SLCO4A1—lung—systemic scleroderma	0.000543	0.03	CbGeAlD
Levothyroxine—Arthralgia—Captopril—systemic scleroderma	0.000542	0.00366	CcSEcCtD
Levothyroxine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000542	0.00366	CcSEcCtD
Levothyroxine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000542	0.00366	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000539	0.00364	CcSEcCtD
Levothyroxine—Arrhythmia—Leflunomide—systemic scleroderma	0.000538	0.00364	CcSEcCtD
Levothyroxine—Hyperkinesia—Prednisone—systemic scleroderma	0.000534	0.00361	CcSEcCtD
Levothyroxine—Alopecia—Leflunomide—systemic scleroderma	0.000533	0.0036	CcSEcCtD
Levothyroxine—Dyspnoea—Mometasone—systemic scleroderma	0.000527	0.00356	CcSEcCtD
Levothyroxine—Confusional state—Captopril—systemic scleroderma	0.000524	0.00354	CcSEcCtD
Levothyroxine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000514	0.00347	CcSEcCtD
Levothyroxine—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00346	CcSEcCtD
Levothyroxine—Shock—Captopril—systemic scleroderma	0.000511	0.00345	CcSEcCtD
Levothyroxine—Fatigue—Mometasone—systemic scleroderma	0.00051	0.00344	CcSEcCtD
Levothyroxine—Alopecia—Mycophenolic acid—systemic scleroderma	0.000508	0.00343	CcSEcCtD
Levothyroxine—Tachycardia—Captopril—systemic scleroderma	0.000507	0.00342	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00336	CcSEcCtD
Levothyroxine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00335	CcSEcCtD
Levothyroxine—Asthenia—Pentoxifylline—systemic scleroderma	0.000492	0.00332	CcSEcCtD
Levothyroxine—Tension—Mycophenolic acid—systemic scleroderma	0.000491	0.00332	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00049	0.00331	CcSEcCtD
Levothyroxine—Nervousness—Mycophenolic acid—systemic scleroderma	0.000486	0.00328	CcSEcCtD
Levothyroxine—Pruritus—Pentoxifylline—systemic scleroderma	0.000485	0.00327	CcSEcCtD
Levothyroxine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00327	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000484	0.00327	CcSEcCtD
Levothyroxine—Flushing—Lisinopril—systemic scleroderma	0.000481	0.00325	CcSEcCtD
Levothyroxine—Angioedema—Leflunomide—systemic scleroderma	0.000479	0.00324	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000473	0.0032	CcSEcCtD
Levothyroxine—Increased appetite—Prednisone—systemic scleroderma	0.000473	0.0032	CcSEcCtD
Levothyroxine—Arthralgia—Azathioprine—systemic scleroderma	0.000473	0.00319	CcSEcCtD
Levothyroxine—Insomnia—Captopril—systemic scleroderma	0.00047	0.00317	CcSEcCtD
Levothyroxine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000469	0.00317	CcSEcCtD
Levothyroxine—Tremor—Mycophenolic acid—systemic scleroderma	0.000469	0.00317	CcSEcCtD
Levothyroxine—Coma—Methotrexate—systemic scleroderma	0.000468	0.00316	CcSEcCtD
Levothyroxine—Abdominal pain—Mometasone—systemic scleroderma	0.000468	0.00316	CcSEcCtD
Levothyroxine—Body temperature increased—Mometasone—systemic scleroderma	0.000468	0.00316	CcSEcCtD
Levothyroxine—SLCO1A2—digestive system—systemic scleroderma	0.000466	0.0257	CbGeAlD
Levothyroxine—Palpitations—Leflunomide—systemic scleroderma	0.000464	0.00313	CcSEcCtD
Levothyroxine—Dyspnoea—Captopril—systemic scleroderma	0.000463	0.00313	CcSEcCtD
Levothyroxine—Arrhythmia—Lisinopril—systemic scleroderma	0.000463	0.00312	CcSEcCtD
Levothyroxine—Agitation—Mycophenolic acid—systemic scleroderma	0.00046	0.00311	CcSEcCtD
Levothyroxine—Alopecia—Lisinopril—systemic scleroderma	0.000458	0.00309	CcSEcCtD
Levothyroxine—Cardiac failure—Prednisone—systemic scleroderma	0.000456	0.00308	CcSEcCtD
Levothyroxine—Fatigue—Captopril—systemic scleroderma	0.000448	0.00302	CcSEcCtD
Levothyroxine—Arthralgia—Leflunomide—systemic scleroderma	0.000447	0.00302	CcSEcCtD
Levothyroxine—Anxiety—Leflunomide—systemic scleroderma	0.000445	0.00301	CcSEcCtD
Levothyroxine—Tension—Lisinopril—systemic scleroderma	0.000442	0.00299	CcSEcCtD
Levothyroxine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000442	0.00299	CcSEcCtD
Levothyroxine—Nervousness—Lisinopril—systemic scleroderma	0.000438	0.00296	CcSEcCtD
Levothyroxine—Affect lability—Prednisone—systemic scleroderma	0.000438	0.00295	CcSEcCtD
Levothyroxine—Vomiting—Pentoxifylline—systemic scleroderma	0.000436	0.00294	CcSEcCtD
Levothyroxine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000434	0.00293	CcSEcCtD
Levothyroxine—Rash—Pentoxifylline—systemic scleroderma	0.000432	0.00292	CcSEcCtD
Levothyroxine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000432	0.00292	CcSEcCtD
Levothyroxine—Headache—Pentoxifylline—systemic scleroderma	0.000429	0.0029	CcSEcCtD
Levothyroxine—Feeling abnormal—Captopril—systemic scleroderma	0.000428	0.00289	CcSEcCtD
Levothyroxine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000426	0.00288	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000425	0.00287	CcSEcCtD
Levothyroxine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000425	0.00287	CcSEcCtD
Levothyroxine—Asthenia—Mometasone—systemic scleroderma	0.000424	0.00287	CcSEcCtD
Levothyroxine—Irritability—Prednisone—systemic scleroderma	0.000424	0.00287	CcSEcCtD
Levothyroxine—Cardiac arrest—Prednisone—systemic scleroderma	0.000423	0.00285	CcSEcCtD
Levothyroxine—Tremor—Lisinopril—systemic scleroderma	0.000422	0.00285	CcSEcCtD
Levothyroxine—Mood swings—Prednisone—systemic scleroderma	0.000421	0.00284	CcSEcCtD
Levothyroxine—ABCB1—blood vessel—systemic scleroderma	0.000421	0.0232	CbGeAlD
Levothyroxine—Pruritus—Mometasone—systemic scleroderma	0.000419	0.00283	CcSEcCtD
Levothyroxine—Tachycardia—Leflunomide—systemic scleroderma	0.000418	0.00282	CcSEcCtD
Levothyroxine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000414	0.00279	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000413	0.00279	CcSEcCtD
Levothyroxine—Angioedema—Lisinopril—systemic scleroderma	0.000412	0.00278	CcSEcCtD
Levothyroxine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000412	0.00278	CcSEcCtD
Levothyroxine—Body temperature increased—Captopril—systemic scleroderma	0.000411	0.00277	CcSEcCtD
Levothyroxine—Abdominal pain—Captopril—systemic scleroderma	0.000411	0.00277	CcSEcCtD
Levothyroxine—Nausea—Pentoxifylline—systemic scleroderma	0.000407	0.00275	CcSEcCtD
Levothyroxine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00274	CcSEcCtD
Levothyroxine—Diarrhoea—Mometasone—systemic scleroderma	0.000405	0.00273	CcSEcCtD
Levothyroxine—Shock—Mycophenolic acid—systemic scleroderma	0.000402	0.00271	CcSEcCtD
Levothyroxine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00271	CcSEcCtD
Levothyroxine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000399	0.00269	CcSEcCtD
Levothyroxine—Palpitations—Lisinopril—systemic scleroderma	0.000398	0.00269	CcSEcCtD
Levothyroxine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000395	0.00267	CcSEcCtD
Levothyroxine—Muscular weakness—Prednisone—systemic scleroderma	0.000392	0.00265	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00039	0.00263	CcSEcCtD
Levothyroxine—SLCO1A2—lung—systemic scleroderma	0.000389	0.0215	CbGeAlD
Levothyroxine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00262	CcSEcCtD
Levothyroxine—Insomnia—Leflunomide—systemic scleroderma	0.000387	0.00261	CcSEcCtD
Levothyroxine—Arthralgia—Lisinopril—systemic scleroderma	0.000384	0.00259	CcSEcCtD
Levothyroxine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000384	0.00259	CcSEcCtD
Levothyroxine—Anxiety—Lisinopril—systemic scleroderma	0.000382	0.00258	CcSEcCtD
Levothyroxine—Dyspnoea—Leflunomide—systemic scleroderma	0.000382	0.00258	CcSEcCtD
Levothyroxine—Vomiting—Mometasone—systemic scleroderma	0.000376	0.00254	CcSEcCtD
Levothyroxine—Sweating increased—Prednisone—systemic scleroderma	0.000374	0.00253	CcSEcCtD
Levothyroxine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000374	0.00252	CcSEcCtD
Levothyroxine—Rash—Mometasone—systemic scleroderma	0.000373	0.00252	CcSEcCtD
Levothyroxine—Asthenia—Captopril—systemic scleroderma	0.000373	0.00252	CcSEcCtD
Levothyroxine—Dermatitis—Mometasone—systemic scleroderma	0.000373	0.00252	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000372	0.00251	CcSEcCtD
Levothyroxine—Confusional state—Lisinopril—systemic scleroderma	0.000371	0.0025	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000371	0.0025	CcSEcCtD
Levothyroxine—Headache—Mometasone—systemic scleroderma	0.000371	0.0025	CcSEcCtD
Levothyroxine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00037	0.0025	CcSEcCtD
Levothyroxine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000369	0.00249	CcSEcCtD
Levothyroxine—Fatigue—Leflunomide—systemic scleroderma	0.000369	0.00249	CcSEcCtD
Levothyroxine—Pruritus—Captopril—systemic scleroderma	0.000368	0.00248	CcSEcCtD
Levothyroxine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000364	0.00246	CcSEcCtD
Levothyroxine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00245	CcSEcCtD
Levothyroxine—Shock—Lisinopril—systemic scleroderma	0.000362	0.00244	CcSEcCtD
Levothyroxine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00244	CcSEcCtD
Levothyroxine—Tachycardia—Lisinopril—systemic scleroderma	0.000359	0.00242	CcSEcCtD
Levothyroxine—Abdominal pain—Azathioprine—systemic scleroderma	0.000358	0.00242	CcSEcCtD
Levothyroxine—Body temperature increased—Azathioprine—systemic scleroderma	0.000358	0.00242	CcSEcCtD
Levothyroxine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000356	0.0024	CcSEcCtD
Levothyroxine—Diarrhoea—Captopril—systemic scleroderma	0.000355	0.0024	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—systemic scleroderma	0.000355	0.00239	CcSEcCtD
Levothyroxine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000353	0.00238	CcSEcCtD
Levothyroxine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000352	0.00238	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—systemic scleroderma	0.000352	0.00238	CcSEcCtD
Levothyroxine—Nausea—Mometasone—systemic scleroderma	0.000351	0.00237	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00035	0.00236	CcSEcCtD
Levothyroxine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00236	CcSEcCtD
Levothyroxine—Weight decreased—Prednisone—systemic scleroderma	0.000348	0.00235	CcSEcCtD
Levothyroxine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00231	CcSEcCtD
Levothyroxine—Urticaria—Leflunomide—systemic scleroderma	0.00034	0.0023	CcSEcCtD
Levothyroxine—Abdominal pain—Leflunomide—systemic scleroderma	0.000339	0.00229	CcSEcCtD
Levothyroxine—Body temperature increased—Leflunomide—systemic scleroderma	0.000339	0.00229	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000338	0.00228	CcSEcCtD
Levothyroxine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000337	0.00227	CcSEcCtD
Levothyroxine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00227	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—systemic scleroderma	0.000336	0.0605	CbGdCrCtD
Levothyroxine—Myocardial infarction—Prednisone—systemic scleroderma	0.000336	0.00227	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000335	0.00226	CcSEcCtD
Levothyroxine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00226	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000334	0.00226	CcSEcCtD
Levothyroxine—Insomnia—Lisinopril—systemic scleroderma	0.000333	0.00225	CcSEcCtD
Levothyroxine—Vomiting—Captopril—systemic scleroderma	0.00033	0.00223	CcSEcCtD
Levothyroxine—Dyspnoea—Lisinopril—systemic scleroderma	0.000328	0.00221	CcSEcCtD
Levothyroxine—Rash—Captopril—systemic scleroderma	0.000328	0.00221	CcSEcCtD
Levothyroxine—Dermatitis—Captopril—systemic scleroderma	0.000327	0.00221	CcSEcCtD
Levothyroxine—Headache—Captopril—systemic scleroderma	0.000325	0.0022	CcSEcCtD
Levothyroxine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00219	CcSEcCtD
Levothyroxine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000323	0.00218	CcSEcCtD
Levothyroxine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000323	0.00218	CcSEcCtD
Levothyroxine—Fatigue—Lisinopril—systemic scleroderma	0.000317	0.00214	CcSEcCtD
Levothyroxine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000317	0.00214	CcSEcCtD
Levothyroxine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00212	CcSEcCtD
Levothyroxine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000312	0.0021	CcSEcCtD
Levothyroxine—Diarrhoea—Azathioprine—systemic scleroderma	0.00031	0.00209	CcSEcCtD
Levothyroxine—Nausea—Captopril—systemic scleroderma	0.000309	0.00208	CcSEcCtD
Levothyroxine—Asthenia—Leflunomide—systemic scleroderma	0.000307	0.00207	CcSEcCtD
Levothyroxine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000303	0.00205	CcSEcCtD
Levothyroxine—Pruritus—Leflunomide—systemic scleroderma	0.000303	0.00205	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000301	0.00203	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000294	0.00198	CcSEcCtD
Levothyroxine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000293	0.00198	CcSEcCtD
Levothyroxine—Diarrhoea—Leflunomide—systemic scleroderma	0.000293	0.00198	CcSEcCtD
Levothyroxine—Urticaria—Lisinopril—systemic scleroderma	0.000292	0.00197	CcSEcCtD
Levothyroxine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00197	CcSEcCtD
Levothyroxine—Abdominal pain—Lisinopril—systemic scleroderma	0.000291	0.00196	CcSEcCtD
Levothyroxine—Body temperature increased—Lisinopril—systemic scleroderma	0.000291	0.00196	CcSEcCtD
Levothyroxine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000289	0.00195	CcSEcCtD
Levothyroxine—Vomiting—Azathioprine—systemic scleroderma	0.000288	0.00195	CcSEcCtD
Levothyroxine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00194	CcSEcCtD
Levothyroxine—Rash—Azathioprine—systemic scleroderma	0.000286	0.00193	CcSEcCtD
Levothyroxine—Dermatitis—Azathioprine—systemic scleroderma	0.000286	0.00193	CcSEcCtD
Levothyroxine—Flushing—Prednisone—systemic scleroderma	0.000285	0.00193	CcSEcCtD
Levothyroxine—Headache—Azathioprine—systemic scleroderma	0.000284	0.00192	CcSEcCtD
Levothyroxine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00028	0.00189	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisone—systemic scleroderma	0.000275	0.00186	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—systemic scleroderma	0.000275	0.00185	CcSEcCtD
Levothyroxine—Vomiting—Leflunomide—systemic scleroderma	0.000272	0.00184	CcSEcCtD
Levothyroxine—Alopecia—Prednisone—systemic scleroderma	0.000272	0.00184	CcSEcCtD
Levothyroxine—Rash—Leflunomide—systemic scleroderma	0.00027	0.00182	CcSEcCtD
Levothyroxine—Dermatitis—Leflunomide—systemic scleroderma	0.00027	0.00182	CcSEcCtD
Levothyroxine—Nausea—Azathioprine—systemic scleroderma	0.000269	0.00182	CcSEcCtD
Levothyroxine—Headache—Leflunomide—systemic scleroderma	0.000268	0.00181	CcSEcCtD
Levothyroxine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00179	CcSEcCtD
Levothyroxine—Asthenia—Lisinopril—systemic scleroderma	0.000264	0.00178	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00178	CcSEcCtD
Levothyroxine—Pruritus—Lisinopril—systemic scleroderma	0.00026	0.00176	CcSEcCtD
Levothyroxine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00026	0.00175	CcSEcCtD
Levothyroxine—Rash—Mycophenolic acid—systemic scleroderma	0.000258	0.00174	CcSEcCtD
Levothyroxine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000257	0.00174	CcSEcCtD
Levothyroxine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00173	CcSEcCtD
Levothyroxine—Headache—Mycophenolic acid—systemic scleroderma	0.000256	0.00173	CcSEcCtD
Levothyroxine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00172	CcSEcCtD
Levothyroxine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00172	CcSEcCtD
Levothyroxine—Nausea—Leflunomide—systemic scleroderma	0.000254	0.00172	CcSEcCtD
Levothyroxine—Diarrhoea—Lisinopril—systemic scleroderma	0.000252	0.0017	CcSEcCtD
Levothyroxine—Agitation—Prednisone—systemic scleroderma	0.000246	0.00166	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—systemic scleroderma	0.000245	0.00165	CcSEcCtD
Levothyroxine—Nausea—Mycophenolic acid—systemic scleroderma	0.000243	0.00164	CcSEcCtD
Levothyroxine—Vomiting—Lisinopril—systemic scleroderma	0.000234	0.00158	CcSEcCtD
Levothyroxine—Rash—Lisinopril—systemic scleroderma	0.000232	0.00157	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—systemic scleroderma	0.000232	0.00157	CcSEcCtD
Levothyroxine—Dermatitis—Lisinopril—systemic scleroderma	0.000232	0.00156	CcSEcCtD
Levothyroxine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000231	0.00156	CcSEcCtD
Levothyroxine—Headache—Lisinopril—systemic scleroderma	0.000231	0.00156	CcSEcCtD
Levothyroxine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00154	CcSEcCtD
Levothyroxine—Arthralgia—Prednisone—systemic scleroderma	0.000228	0.00154	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—systemic scleroderma	0.000227	0.00153	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—systemic scleroderma	0.000227	0.00153	CcSEcCtD
Levothyroxine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00149	CcSEcCtD
Levothyroxine—CYP3A4—digestive system—systemic scleroderma	0.00022	0.0122	CbGeAlD
Levothyroxine—Nausea—Lisinopril—systemic scleroderma	0.000219	0.00148	CcSEcCtD
Levothyroxine—Shock—Prednisone—systemic scleroderma	0.000215	0.00145	CcSEcCtD
Levothyroxine—Tachycardia—Prednisone—systemic scleroderma	0.000213	0.00144	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000211	0.00143	CcSEcCtD
Levothyroxine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000205	0.00138	CcSEcCtD
Levothyroxine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00137	CcSEcCtD
Levothyroxine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00137	CcSEcCtD
Levothyroxine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00136	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000199	0.00134	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—systemic scleroderma	0.000198	0.00133	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—systemic scleroderma	0.000194	0.00131	CcSEcCtD
Levothyroxine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00129	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—systemic scleroderma	0.000191	0.00129	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—systemic scleroderma	0.000188	0.00127	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—systemic scleroderma	0.000184	0.00124	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—systemic scleroderma	0.00018	0.00122	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000179	0.00121	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000177	0.00119	CcSEcCtD
Levothyroxine—Urticaria—Prednisone—systemic scleroderma	0.000174	0.00117	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—systemic scleroderma	0.000173	0.00117	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—systemic scleroderma	0.000173	0.00117	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000166	0.00112	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—systemic scleroderma	0.000165	0.00112	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—systemic scleroderma	0.000163	0.0011	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—systemic scleroderma	0.000157	0.00106	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—systemic scleroderma	0.000157	0.00106	CcSEcCtD
Levothyroxine—ABCB1—digestive system—systemic scleroderma	0.000156	0.00861	CbGeAlD
Levothyroxine—Pruritus—Prednisone—systemic scleroderma	0.000155	0.00104	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00015	0.00102	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—systemic scleroderma	0.00015	0.00101	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000149	0.00101	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—systemic scleroderma	0.000145	0.00098	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—systemic scleroderma	0.000144	0.000975	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—systemic scleroderma	0.000144	0.000975	CcSEcCtD
Levothyroxine—Vomiting—Prednisone—systemic scleroderma	0.000139	0.000938	CcSEcCtD
Levothyroxine—Rash—Prednisone—systemic scleroderma	0.000138	0.00093	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—systemic scleroderma	0.000138	0.000929	CcSEcCtD
Levothyroxine—Headache—Prednisone—systemic scleroderma	0.000137	0.000924	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—systemic scleroderma	0.000131	0.000885	CcSEcCtD
Levothyroxine—ABCB1—lung—systemic scleroderma	0.00013	0.00719	CbGeAlD
Levothyroxine—Nausea—Prednisone—systemic scleroderma	0.00013	0.000876	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—systemic scleroderma	0.000129	0.000872	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—systemic scleroderma	0.000125	0.000844	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—systemic scleroderma	0.000116	0.000784	CcSEcCtD
Levothyroxine—Rash—Methotrexate—systemic scleroderma	0.000115	0.000777	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—systemic scleroderma	0.000115	0.000777	CcSEcCtD
Levothyroxine—Headache—Methotrexate—systemic scleroderma	0.000114	0.000772	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—systemic scleroderma	0.000108	0.000732	CcSEcCtD
Levothyroxine—TTR—Retinoid metabolism and transport—HSPG2—systemic scleroderma	5.32e-05	0.0602	CbGpPWpGaD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—HSPG2—systemic scleroderma	5.22e-05	0.0591	CbGpPWpGaD
Levothyroxine—SLC7A5—Basigin interactions—MMP1—systemic scleroderma	4.29e-05	0.0486	CbGpPWpGaD
Levothyroxine—TTR—Amyloids—TGFBI—systemic scleroderma	3.91e-05	0.0442	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	3.56e-05	0.0403	CbGpPWpGaD
Levothyroxine—TTR—Amyloids—HSPG2—systemic scleroderma	3.12e-05	0.0353	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	2.85e-05	0.0322	CbGpPWpGaD
Levothyroxine—TTR—Diseases associated with visual transduction—HSPG2—systemic scleroderma	2.72e-05	0.0307	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	2.34e-05	0.0265	CbGpPWpGaD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	2.34e-05	0.0265	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL13—systemic scleroderma	2.19e-05	0.0248	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—FBN1—systemic scleroderma	1.71e-05	0.0194	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.63e-05	0.0184	CbGpPWpGaD
Levothyroxine—ALB—Lipoprotein metabolism—HSPG2—systemic scleroderma	1.62e-05	0.0184	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—SMAD7—systemic scleroderma	1.48e-05	0.0168	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—SMAD7—systemic scleroderma	1.48e-05	0.0168	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	1.43e-05	0.0162	CbGpPWpGaD
Levothyroxine—THRA—Endochondral Ossification—MMP9—systemic scleroderma	1.38e-05	0.0157	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	1.38e-05	0.0156	CbGpPWpGaD
Levothyroxine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—systemic scleroderma	1.26e-05	0.0143	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	1.26e-05	0.0143	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—HSPG2—systemic scleroderma	1.2e-05	0.0136	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—COL1A2—systemic scleroderma	1.2e-05	0.0136	CbGpPWpGaD
Levothyroxine—THRA—Endochondral Ossification—TGFB1—systemic scleroderma	1.14e-05	0.0129	CbGpPWpGaD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—TGFB1—systemic scleroderma	1.14e-05	0.0129	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—ITGAM—systemic scleroderma	1.09e-05	0.0123	CbGpPWpGaD
Levothyroxine—ALB—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	1.08e-05	0.0122	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—SELP—systemic scleroderma	9.66e-06	0.0109	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—CSF1—systemic scleroderma	9.47e-06	0.0107	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—RHOB—systemic scleroderma	9.02e-06	0.0102	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—SELP—systemic scleroderma	8.41e-06	0.00952	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—CSK—systemic scleroderma	8.21e-06	0.00929	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—CTGF—systemic scleroderma	8.21e-06	0.00929	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—CTGF—systemic scleroderma	8.21e-06	0.00929	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	8.02e-06	0.00907	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ITGAM—systemic scleroderma	7.72e-06	0.00874	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	7.19e-06	0.00814	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—SMAD7—systemic scleroderma	7.15e-06	0.00809	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—SMAD7—systemic scleroderma	7.15e-06	0.00809	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—TNFSF13—systemic scleroderma	6.64e-06	0.00752	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—TNFSF13—systemic scleroderma	6.64e-06	0.00752	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL13—systemic scleroderma	5.61e-06	0.00635	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP1—systemic scleroderma	5.46e-06	0.00618	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	4.98e-06	0.00563	CbGpPWpGaD
Levothyroxine—TTR—Disease—SMAD7—systemic scleroderma	4.73e-06	0.00535	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	4.51e-06	0.00511	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFBI—systemic scleroderma	4.32e-06	0.0049	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP2—systemic scleroderma	4.22e-06	0.00478	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	4.1e-06	0.00464	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.02e-06	0.00455	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—CTGF—systemic scleroderma	3.95e-06	0.00447	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—CTGF—systemic scleroderma	3.95e-06	0.00447	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	3.93e-06	0.00445	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—MMP1—systemic scleroderma	3.87e-06	0.00438	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	3.73e-06	0.00422	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	3.72e-06	0.00421	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	3.53e-06	0.00399	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	3.51e-06	0.00397	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	3.48e-06	0.00394	CbGpPWpGaD
Levothyroxine—TTR—Disease—HSPG2—systemic scleroderma	3.45e-06	0.0039	CbGpPWpGaD
Levothyroxine—TTR—Disease—CSK—systemic scleroderma	3.33e-06	0.00377	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SMAD7—systemic scleroderma	3.31e-06	0.00375	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—CCL2—systemic scleroderma	3.2e-06	0.00362	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP9—systemic scleroderma	3.17e-06	0.00359	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	3.17e-06	0.00359	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.16e-06	0.00357	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD247—systemic scleroderma	3.13e-06	0.00355	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.04e-06	0.00345	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	2.98e-06	0.00337	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NOS3—systemic scleroderma	2.8e-06	0.00317	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.7e-06	0.00305	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—TGFB1—systemic scleroderma	2.62e-06	0.00296	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RHOB—systemic scleroderma	2.56e-06	0.0029	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	2.54e-06	0.00288	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL1B—systemic scleroderma	2.43e-06	0.00275	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HSPG2—systemic scleroderma	2.42e-06	0.00273	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.39e-06	0.00271	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CSK—systemic scleroderma	2.33e-06	0.00264	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.05e-06	0.00232	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	1.93e-06	0.00218	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SELP—systemic scleroderma	1.92e-06	0.00218	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TGFB1—systemic scleroderma	1.85e-06	0.0021	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	1.84e-06	0.00208	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RHOB—systemic scleroderma	1.8e-06	0.00203	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—HSPG2—systemic scleroderma	1.79e-06	0.00202	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CSK—systemic scleroderma	1.64e-06	0.00185	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—TGFB1—systemic scleroderma	1.62e-06	0.00183	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.55e-06	0.00176	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.54e-06	0.00175	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	1.54e-06	0.00174	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ITGAM—systemic scleroderma	1.54e-06	0.00174	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	1.43e-06	0.00162	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	1.41e-06	0.00159	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CTGF—systemic scleroderma	1.36e-06	0.00153	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EDN1—systemic scleroderma	1.31e-06	0.00148	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	1.2e-06	0.00136	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.18e-06	0.00133	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.17e-06	0.00132	CbGpPWpGaD
Levothyroxine—TTR—Disease—NOS3—systemic scleroderma	1.14e-06	0.00129	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CTGF—systemic scleroderma	1.07e-06	0.00121	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CTGF—systemic scleroderma	9.11e-07	0.00103	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL2—systemic scleroderma	8.94e-07	0.00101	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NOS3—systemic scleroderma	7.97e-07	0.000902	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MMP1—systemic scleroderma	7.71e-07	0.000872	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—systemic scleroderma	7.52e-07	0.000852	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	7.17e-07	0.000811	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	7.06e-07	0.000799	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	6.91e-07	0.000782	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HSPG2—systemic scleroderma	6.87e-07	0.000777	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—systemic scleroderma	6.39e-07	0.000724	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HSPG2—systemic scleroderma	6.02e-07	0.000681	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NOS3—systemic scleroderma	5.9e-07	0.000668	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS3—systemic scleroderma	5.59e-07	0.000632	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—systemic scleroderma	5.27e-07	0.000596	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CTGF—systemic scleroderma	5.23e-07	0.000592	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CTGF—systemic scleroderma	5.2e-07	0.000589	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—systemic scleroderma	4.64e-07	0.000525	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CTGF—systemic scleroderma	4.56e-07	0.000516	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—systemic scleroderma	3.96e-07	0.000449	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	3.71e-07	0.00042	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—systemic scleroderma	3.69e-07	0.000418	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CTGF—systemic scleroderma	2.81e-07	0.000318	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—systemic scleroderma	2.28e-07	0.000258	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—systemic scleroderma	2.27e-07	0.000256	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—systemic scleroderma	1.98e-07	0.000225	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—systemic scleroderma	1.22e-07	0.000138	CbGpPWpGaD
